SIRPA and cancer: Our in vitro studies demonstrated that 1B2–10 effectively disrupted the interaction between CD47 and SIRPα, thereby abrogating the “don’t eat me” signal and resulting in a significant enhancement of macrophage-mediated phagocytosis against CD47-expressing cancer cell lines.